Here are some key factors that make Serbia an essential part of our clinical research network:
📍 Strategic location: While Serbia is not an EU member state, it enjoys partnerships with the United States and benefits from preferential trade agreements with the EU, EMA, CEFTA, and EFTA.
🔎 Regulatory advantages: Serbia boasts an enhanced regulatory framework with validated safety guidelines under local law, overseen by the Medical Devices Agency.
📋 Efficient patient recruitment: Serbia offers high recruitment rates and a diverse patient population.
👨⚕️ Skilled workforce: Serbia ensures adherence to global clinical research standards by a well-educated, highly trained workforce as well.
🔬 Commitment to quality: The clinical research sector in Serbia is growing rapidly and upholding high-quality standards.
At BiTrial, we offer strong country capabilities, backed by an established network of sites and experts.
Contact Us!